
Symptomatic improvement using everolimus in infants with cardiac rhabdomyoma
Author(s) -
Bhargavi Dhulipudi,
Shweta Bhakru,
Sudarsan Rajan,
Vinoth Doraiswamy,
Nageswara Rao Koneti
Publication year - 2019
Publication title -
annals of pediatric cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 19
eISSN - 0974-2069
pISSN - 0974-5149
DOI - 10.4103/apc.apc_79_18
Subject(s) - medicine , rhabdomyoma , everolimus , intensive care medicine , pediatrics , cardiology , radiology , tuberous sclerosis
Cardiac rhabdomyoma (CR) often shows spontaneous regression and needs close follow-up. These tumors may be associated with tuberous sclerosis complex (TSC), caused by the disinhibition of m-TOR protein.